Where to Buy Multisample Blood Collection Needles in the U.S.agext

Summary

• Reputable U.S. purchasing options for multisample blood collection needles include established manufacturers such as BD, Greiner Bio-One, and Terumo, as well as distributors such as Cardinal Health, McKesson Medical-Surgical, Medline, and Henry Schein.
• Buyers should evaluate needle safety features, gauge and length, tube compatibility, sterile packaging, regulatory documentation, lot traceability, contract terms, and total cost rather than choosing solely on unit price.
• Because Needlestick Injuries remain a significant occupational hazard, U.S. facilities should generally prioritize safety-engineered multisample needles and maintain purchasing practices consistent with OSHA, FDA, CDC, and state requirements.

Multisample blood collection needles are widely used in hospitals, physician offices, outpatient laboratories, urgent-care clinics, blood-drawing centers, Mobile Phlebotomy services, and long-term-care facilities. These devices are designed to permit collection into multiple evacuated blood tubes during a single Venipuncture. A typical assembly includes a sterile needle, a tube-facing rubber sleeve or valve, and a hub that connects to a compatible holder. After the first tube is filled and removed, the sleeve allows the next tube to be inserted while helping prevent blood leakage through the back end of the needle.

For U.S. buyers, selecting a supplier is more complicated than comparing catalog prices. A reliable supplier must provide products that are appropriate for the intended patient population, compatible with the facility’s blood collection tubes and holders, supported by clear regulatory and quality documentation, and consistently available. The purchasing decision also has an important worker-safety dimension. Needles are among the most common sources of occupational exposure to blood and other potentially infectious materials, making safety-engineered options especially important.

What Are Multisample Blood Collection Needles?

A multisample needle is a Venipuncture needle designed for use with evacuated blood collection tubes. Unlike a single-draw needle intended for one collection container, a multisample needle permits several tubes to be collected without removing the needle from the patient. The needle is normally used with a tube holder, which supports the collection tube and helps the phlebotomist maintain the correct angle during Venipuncture.

Common needle gauges include 18, 20, 21, 22, and 23 gauge. A 21-gauge needle is frequently used for routine adult Venipuncture because it provides a balance between blood flow and patient comfort. A 22-gauge needle may be useful for smaller or fragile veins, while 23-gauge products are often selected for difficult draws, pediatric patients, or individuals with small veins. Gauge selection must be based on the procedure, patient condition, required flow rate, and the laboratory’s validated practices.

Needle lengths commonly range from approximately 1 inch to 1.5 inches for routine Venipuncture, although longer or shorter versions may be available for specialized applications. Some products feature a pre-attached holder, while others are supplied as a separate needle and holder. Safety versions may include a hinged shield, sliding shield, push-button activation, or other mechanism intended to cover the sharp immediately after use.

Why Supplier Reputation Matters

The quality of a blood collection needle can affect patient comfort, Specimen Integrity, staff safety, and operational efficiency. A poorly manufactured or inconsistent needle may produce excessive pain, premature loss of vacuum, tube leakage, hemolysis, incomplete draws, or repeated Venipuncture attempts. Even when a product meets basic specifications, differences in bevel design, lubrication, tubing, hub fit, and safety activation can influence the user experience.

Supplier reliability is also important because medical facilities need continuity of supply. A laboratory may process hundreds or thousands of specimens per day, and a shortage of the preferred Needle Gauge can disrupt staffing, increase redraws, or force the facility to use unfamiliar products. During the Covid-19 pandemic, the U.S. medical Supply Chain experienced significant pressure involving needles, syringes, tubes, personal protective equipment, and other consumables. That experience reinforced the value of dual sourcing, safety stock, and transparent allocation policies.

U.S. employers also have regulatory responsibilities. The Occupational Safety and Health Administration’s Bloodborne Pathogens Standard requires employers with occupational exposure to blood or other potentially infectious materials to use engineering and work-practice controls, maintain exposure-control plans, and evaluate safer medical devices when appropriate. The Needlestick Safety and Prevention Act strengthened these requirements by emphasizing employee input and the selection of safer needle technologies.

The Centers for Disease Control and Prevention has historically estimated that hospital-based healthcare personnel experience roughly 385,000 needlestick and other sharps injuries each year in the United States. The true number may be higher because injuries are not always reported. A facility’s supplier-selection process should therefore consider injury prevention, not merely the lowest acquisition cost.

Leading Manufacturers of Multisample Needles

BD

BD, formerly known as Becton, Dickinson and Company, is one of the most recognized manufacturers of blood collection products in the United States. Its Vacutainer product family is commonly used with evacuated blood collection tubes, tube holders, transfer devices, and safety accessories. BD offers conventional multisample needle configurations as well as safety-engineered options designed to reduce the risk of accidental Needlestick Injuries.

BD is often considered by hospitals and laboratories that want an integrated blood collection system. Buyers can typically standardize the needle, holder, tube, and accessory combination under one product family, which may simplify staff training and inventory management. However, facilities should verify that the specific needle is compatible with their current tubes and holders and that the product configuration meets their organization’s safety policy.

When evaluating BD products, purchasers should confirm the exact catalog number, gauge, length, safety mechanism, sterile packaging, and whether the product is supplied with or without a holder. Large health systems may also obtain BD products through group purchasing contracts or direct institutional agreements.

Greiner Bio-One

Greiner Bio-One is another established manufacturer of blood collection products used in the United States. Its VACUETTE product family includes evacuated blood collection tubes, holders, needles, safety devices, and related laboratory accessories. Greiner’s multisample needles are generally considered by laboratories that use or are evaluating the VACUETTE collection system.

A major advantage of considering Greiner Bio-One is the ability to source multiple components from a single blood collection platform. This can help a laboratory align tube additives, needle assemblies, holders, and specimen-processing procedures. Buyers should nevertheless conduct validation before changing brands because tube dimensions, vacuum characteristics, additives, and device interfaces may vary between manufacturers.

Greiner products may be purchased through authorized medical distributors, laboratory supply companies, or institutional contracts. The buyer should confirm that the distributor is authorized and that the products are intended for the U.S. market, particularly when purchasing through online marketplaces or secondary channels.

Terumo

Terumo is a global medical device manufacturer with a substantial presence in vascular access, injection, infusion, and blood collection products. Terumo’s needle offerings may include conventional and safety-engineered configurations used in clinical blood collection. Product availability can vary by distributor, region, and contract arrangement.

Terumo is a useful option for facilities seeking an additional qualified manufacturer or a product that may have different bevel, lubrication, hub, or safety characteristics from their current brand. A clinical evaluation is advisable before conversion. Phlebotomists should assess ease of insertion, flashback visibility, tube changes, safety activation, and the frequency of redraws or specimen-quality problems.

Major U.S. Medical Distributors

Cardinal Health

Cardinal Health is one of the largest healthcare distribution companies serving hospitals, laboratories, physician practices, and other healthcare organizations in the United States. It distributes a wide range of blood collection needles and related products, including items from major manufacturers and private-label or customer-specific product lines.

Cardinal Health may be particularly suitable for larger facilities that want to consolidate orders for needles, tubes, gloves, disinfectants, sharps containers, and other medical supplies. Its value is often related to logistics, distribution infrastructure, inventory programs, and contract management rather than manufacturing every product it sells.

Healthcare organizations should ask whether a quoted needle is a manufacturer-branded item, a private-label product, or an equivalent substitution. The facility should also confirm substitution rules, back-order procedures, expiration-date policies, and emergency allocation processes before finalizing an agreement.

McKesson Medical-Surgical

McKesson Medical-Surgical is a major U.S. distributor serving hospitals, ambulatory care centers, laboratories, physician practices, and other Healthcare Providers. It offers blood collection needles from recognized manufacturers and may provide both routine and safety-engineered options.

McKesson can be convenient for organizations that already purchase general medical supplies through its platform. Consolidating products can reduce the administrative burden associated with multiple vendors and may make it easier to track purchase history, lot information, and contract pricing. Small practices should confirm minimum order quantities, freight charges, delivery schedules, and return procedures.

Because distributor catalogs may contain several similar-looking products, purchasers should use the exact manufacturer and catalog number when ordering. A description such as “21-gauge multisample needle” is not sufficient by itself. The order should identify the needle length, safety design, holder configuration, sterile packaging, quantity per box, and quantity per case.

Medline

Medline is a major U.S. medical supply manufacturer and distributor with products serving acute care, ambulatory care, long-term care, home care, and laboratory environments. It offers blood collection and Venipuncture products through its own product lines and through distribution arrangements.

Medline may be attractive to facilities seeking a broad product portfolio, consolidated purchasing, and support with standardization. In addition to multisample needles, a buyer may source tube holders, tourniquets, alcohol prep pads, gauze, bandages, sharps containers, and specimen transport supplies from the same vendor.

As with any private-label or alternative product, facilities should review the technical documentation and conduct a controlled trial. A lower-priced product may not reduce total cost if it increases unsuccessful draws, Specimen Rejection, staff training time, or sharps injuries.

Henry Schein

Henry Schein is a prominent distributor serving dental, medical, and ambulatory healthcare practices. Physician offices, independent laboratories, outpatient clinics, and smaller practices may use Henry Schein for phlebotomy needles and other clinical consumables.

Its distribution model can be useful for offices that do not have the purchasing volume of a large hospital system. Buyers should compare case pricing with individual-box pricing, review shipping thresholds, and determine whether the supplier offers standing orders or automatic replenishment. Smaller facilities should also check product expiration dates and storage requirements because low-volume use can increase the risk of holding inventory too long.

Other Procurement Channels

In addition to the major manufacturers and distributors, U.S. buyers may purchase multisample needles through regional laboratory suppliers, state or regional group purchasing organizations, independent medical supply companies, and authorized e-commerce platforms. These channels can be legitimate and cost-effective, but the buyer must perform more due diligence when the supplier is unfamiliar.

Online marketplaces require particular caution. A listing may use a familiar brand name but provide limited information about the seller, product origin, storage history, or expiration date. Medical facilities should avoid products with damaged packaging, missing lot numbers, unclear labeling, unusually low prices, or descriptions that do not identify the manufacturer and catalog number.

Purchasers should not assume that a product is appropriate merely because it is listed as “medical grade.” The facility should obtain a manufacturer’s instructions for use, product specifications, sterility information, and evidence that the product is legally marketed for the intended use in the United States. Where applicable, buyers should also verify the manufacturer’s U.S. regulatory status and review FDA safety communications or recalls.

How to Compare Suppliers and Products

A structured evaluation helps prevent purchasing decisions based solely on unit price. The following factors are especially important when comparing suppliers.

1. Product identity: Record the manufacturer, product family, catalog number, gauge, needle length, safety configuration, holder compatibility, and packaging quantity.

2. Regulatory documentation: Request instructions for use, labeling, sterilization information, product specifications, and applicable regulatory documentation. Confirm that the product is intended for the U.S. market.

3. Safety design: Determine whether the device has a safety feature and whether it can be activated with one hand, preferably while the needle remains in the patient’s view. Review whether activation is automatic or manual and whether it provides an audible or visual confirmation.

4. Compatibility: Test the needle with the facility’s evacuated tubes, holders, adapters, and blood collection Workflow. Confirm that tubes engage properly and that the needle does not cause unusual leakage or loss of vacuum.

5. Specimen quality: Monitor hemolysis, clotting, underfilled tubes, redraws, rejected specimens, and other laboratory-quality indicators during a product trial.

6. Supply continuity: Ask about manufacturing locations, normal lead times, allocation policies, back-order communication, substitute products, and contingency inventory.

7. Traceability: Ensure that boxes and cases display lot numbers, expiration dates, manufacturer information, and sufficient information for recall management.

8. Commercial terms: Compare unit price, case quantity, freight, rebates, contract commitments, payment terms, returns, and price-adjustment provisions.

9. Customer support: Evaluate the supplier’s response time, product-training resources, complaint handling, and process for reporting adverse events or quality concerns.

Safety-Engineered Needles Versus Conventional Needles

Conventional multisample needles may be less expensive, but they do not provide the same level of protection as safety-engineered devices. A safety needle is designed to reduce exposure after Venipuncture by covering or otherwise neutralizing the sharp. Depending on the design, activation may occur automatically or require the user to engage a shield.

OSHA requires employers to consider safer medical devices when feasible and to document their evaluation of engineering controls. Employee input is also an important part of the process. Phlebotomists, nurses, and laboratory personnel should participate in product trials because they understand the practical challenges of activation, tube changes, patient positioning, and disposal.

Safety devices are not a substitute for training. Staff must still use appropriate gloves and other personal protective equipment, avoid recapping, dispose of needles immediately in approved sharps containers, and follow the facility’s exposure-control plan. A safety feature that is difficult to activate or incompatible with the Workflow may not provide its intended benefit.

When comparing total cost, include the potential financial consequences of occupational exposures. These may involve emergency evaluation, laboratory testing, prophylactic medication, employee time, incident documentation, workers’ compensation, and regulatory reporting. The purchase price difference between conventional and safety-engineered needles should therefore be evaluated against the organization’s safety objectives and exposure-prevention program.

Regulatory and Quality Considerations in the United States

The U.S. Food and Drug Administration regulates medical devices, including many blood collection and needle products. Buyers should retain product labeling and manufacturer documentation and establish a process for reviewing recalls, safety notices, and product changes. The exact regulatory pathway and classification can vary by device type and intended use, so procurement teams should rely on manufacturer documentation and applicable FDA requirements rather than making assumptions from a product name.

Healthcare organizations should also maintain a documented vendor-qualification process. This may include checking the supplier’s legal business identity, distribution authorization, quality certifications, complaint history, insurance, business continuity procedures, and ability to provide lot-level traceability. Larger systems may require supplier questionnaires, audits, or evidence of quality-management-system compliance.

Storage and transportation conditions matter as well. Sterile needles should remain in their original packaging and be protected from moisture, excessive heat, crushing, and contamination. Inventory should be rotated using a first-expire, first-out method. Facilities should avoid accepting cases with crushed cartons, broken seals, illegible labels, or insufficient remaining shelf life.

Recommended Purchasing Process

A practical purchasing process begins with a needs assessment. Determine the number of blood draws performed each month, the percentage of adult and pediatric patients, the most frequently used gauges and lengths, the current needlestick rate, and the number of rejected or redrawn specimens. This information helps the organization select appropriate products and estimate demand.

Next, create a short list of manufacturers and distributors. A common approach is to obtain proposals from at least two established manufacturers or distributors and request samples for clinical evaluation. The trial should use the same tubes, holders, and collection procedures used in routine practice. Feedback should be collected from phlebotomists, nurses, laboratory staff, infection-prevention personnel, materials management, and occupational health.

During the trial, measure both technical and operational results. Useful indicators include first-attempt success rate, patient-reported discomfort, Specimen Rejection rate, hemolysis rate, time per draw, safety-feature activation rate, and user-reported problems. The organization should define an evaluation period long enough to identify issues across different staff members and patient types.

After selection, establish reorder points and safety stock. Demand forecasting should account for seasonal fluctuations, new clinical programs, emergency use, and supplier lead times. A facility that uses 10,000 needles per month may need a different buffer than a small physician office that uses only several hundred. The appropriate stock level should be determined through documented supply-risk analysis rather than an arbitrary number of cases.

Questions to Ask a Potential Supplier

1. Is the supplier authorized to distribute the manufacturer’s products in the United States?

2. What are the exact manufacturer name, catalog number, gauge, length, and safety configuration?

3. Are the needles compatible with the facility’s current tube holders and evacuated tubes?

4. What is the average lead time, and how does the supplier handle back orders or allocations?

5. Can the supplier provide lot numbers, expiration dates, certificates, instructions for use, and recall notifications?

6. Does the supplier permit clinical samples or a limited product trial before a large purchase?

7. What are the minimum order, case quantity, freight charges, return terms, and substitution policies?

8. How are complaints, adverse events, damaged shipments, and suspected counterfeit products handled?

9. Does the supplier offer training or technical assistance for safety-device activation?

10. Can the supplier support continuity of supply through multiple distribution centers or an approved secondary source?

Balancing Price and Total Cost

Price remains an important consideration, particularly for high-volume laboratories. However, the quoted price per needle is only one component of total cost. Other costs may include shipping, inventory storage, product waste, staff training, rejected specimens, redraws, treatment of occupational exposures, and time spent resolving supply problems.

For example, a product that costs slightly more per unit may be economically preferable if it reduces failed venipunctures, hemolysis, or injuries. Conversely, an expensive product may not deliver value if its safety mechanism is rarely activated or if it is incompatible with existing holders. A well-designed product trial allows the facility to compare cost and performance using its own data.

Group purchasing organizations may provide negotiated pricing and standardized contracts for hospitals and larger networks. Independent practices may benefit from distributor volume discounts or standing orders. Contract terms should be reviewed carefully for automatic substitutions, minimum commitments, annual price increases, and restrictions on purchasing equivalent products from other suppliers.

Practical Supplier Shortlist

For many U.S. healthcare organizations, a reasonable initial shortlist may include BD, Greiner Bio-One, and Terumo as manufacturers, along with Cardinal Health, McKesson Medical-Surgical, Medline, and Henry Schein as distribution options. This is not a guarantee that every product from these companies will suit every facility. Product availability, contract status, regional service, pricing, and regulatory documentation should be verified for the specific item under consideration.

Hospitals and large laboratories may prefer direct manufacturer relationships or group purchasing contracts that provide predictable allocation and technical support. Physician offices and smaller outpatient facilities may find a national distributor more convenient because it can combine multisample needles with other clinical supplies. Independent laboratories may prioritize compatibility with their existing tube system, analyzer Workflow, and specimen-quality requirements.

Final Recommendations

The most reputable supplier is the one that can consistently provide a correctly identified, legally marketed, sterile, traceable, and clinically suitable product while supporting the facility’s safety and continuity requirements. Well-known names such as BD, Greiner Bio-One, Terumo, Cardinal Health, McKesson Medical-Surgical, Medline, and Henry Schein are sensible starting points for a U.S. procurement review, but reputation should be confirmed at the product and contract level.

Before placing a large order, verify the exact catalog number, test the needle in the real clinical Workflow, consult the staff who will use it, and document the evaluation. Give special attention to safety-engineered designs, OSHA obligations, product compatibility, specimen-quality results, expiration dates, and emergency supply arrangements.

A disciplined purchasing strategy protects patients, healthcare workers, and laboratory operations. By comparing established manufacturers and distributors on quality, safety, supply continuity, and total cost—not just price—U.S. healthcare organizations can make a more defensible decision when purchasing multisample blood collection needles.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos